Injectafer Drug Interactions: 1 Major, 14 Moderate
Injectafer (Ferric Carboxymaltose Injection) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Injectafer. Always confirm against the full prescribing information.
24 interactions
Carbidopa
Ferric carboxymaltose can cause a decrease in the absorption of Carbidopa resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Ciprofloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Ferric carboxymaltose.
Level 1 evidence
Delafloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Gatifloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Gemifloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Levofloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Lomefloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Methyldopa
Ferric carboxymaltose can cause a decrease in the absorption of Methyldopa resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Moxifloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Ofloxacin
Ferric carboxymaltose can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Omeprazole
The absorption of Ferric carboxymaltose can be decreased when combined with Omeprazole.
Level 2 evidence
Enter your NPI to unlock 1 major interaction for Injectafer
Injectafer (Ferric Carboxymaltose Injection) has 24 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Injectafer (Ferric Carboxymaltose Injection) has 1 major, 14 moderate, and 9 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Injectafer. Always confirm against the full prescribing information.